跳至主要内容
临床试验/jRCT2062260015
jRCT2062260015招募中不适用

Exploratory, Single-arm, Single-center, Investigator-initiated Clinical Trial to Evaluate Safety and Efficacy of Subretinal Implantation of OUH-MU001 Using OUH-MU Injector in Patients with Retinitis Pigmentosa (OUReP001)

未提供0 个研究点目标入组 3 人开始时间: 待定
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study

入排标准

年龄范围
No limit 至 No limit(—)
性别
All

入选标准

  • The patient has been diagnosed with retinitis pigmentosa.
  • There is no corneal opacity in the eye, and the visual acuity is light perception.
  • The visual acuity of the fellow eye is diagnosed as light perception, hand movement or counting fingers.
  • The retinal imaging of the eye by optical coherence tomography (OCT) demonstrates preservation of two retinal layers, namely the nerve fiber layer and the inner plexiform layer.
  • Cataract surgery in the study eye was performed at least two weeks prior to the screening.
  • The patient has cognitive capacity.
  • Written informed consent to participate in this clinical trial has been obtained.
  • It has been determined that the observations and examinations specified in the protocol can be performed.

排除标准

  • The study eye has other ocular diseases except for retinitis pigmentosa.
  • (1) Glaucoma
  • (2) Optic nerve atrophy
  • (3) Corneal opacity
  • (4) Acute ocular infection
  • There is a history of retinal detachment surgery in the study eye, except for laser treatment for retinal tears.
  • The fundus cannot be visualized due to cataract in the study eye.
  • Cataract surgery was performed within two weeks prior to the start of screening.
  • The investigator judges that there is a history of drug allergy.
  • ECOG Performance Status is 3 or higher.
  • The patient has serious comorbidities such as hepatic, renal, cardiac, pulmonary, hematologic, metabolic, or psychiatric disorders.
  • The patient is pregnant, breastfeeding, possibly pregnant, intends to become pregnant during the study period, or cannot agree to contraception during the study period.
  • The patient is participating in another clinical trial or interventional clinical study, or less than three months have passed since completion of follow-up for such a trial or study.
  • The investigator judges the patient to be unsuitable for enrollment from social or ethical perspectives.

研究者

发起方
未提供

相似试验